Label Reconciliation
ProductionAlso known as: Label accountability, Label count reconciliation, Packaging reconciliation
Accounting for all labels issued vs used vs destroyed during a production run. Required for dietary supplements under 21 CFR 111.410(b), unless a 100% electronic or electromechanical examination is used for cut or rolled labels.
What It Means
Label reconciliation is the process of accounting for the quantity of labels issued for a production run versus the number applied to finished product, with any discrepancy investigated. For dietary supplements it is required by 21 CFR 111.410(b) (Subpart L, Packaging and Labeling Operations): you must control the issuance and use of packaging and labels and reconcile any issuance/use discrepancies, unless a 100% examination for correct labels is performed by appropriate electronic or electromechanical equipment for cut or rolled labels. The drug cGMP rule (21 CFR 211.125) imposes the same reconciliation-with-exemption on finished pharmaceuticals. The purpose is to prevent obsolete, incorrect, or excess labels from being applied to the wrong products. Reconciliation is closely linked to changeover control: production line changeovers (switching from Product A to Product B) are where mislabeling errors most commonly occur.
What It Is Not
Label reconciliation is NOT simply counting labels. It requires investigating discrepancies (more or fewer labels than expected), destroying excess labels, and maintaining records. For supplements it is required by 21 CFR 111.410(b) (Subpart L): control label issuance and use, and reconcile discrepancies, with the cut/roll-label exemption when 100% electronic examination is used; 21 CFR 211.125 is the parallel drug cGMP rule. The electronic-examination exemption exists because such systems catch mislabeling in real time, making the manual count redundant.
Evidence and References
- regulation21 CFR 111.410(b) (Subpart L) - control of packaging/label issuance and reconciliation of discrepancies, with the cut/roll-label 100%-examination exemption
- regulation21 CFR 211.125 (drug cGMP): parallel label-reconciliation requirement for finished pharmaceuticals
- discussionIFSQN forum: label reconciliation under SQF
Related Categories
Need Help Understanding Compliance?
Our directory connects you with manufacturers and labs that meet these standards.